Seneca Biopharma, Inc. Income Statement 2011-2024 | SNCA

	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	538 K	425 K	1.06 M	4.01 M	4.12 M	11.8 M	45 M	39 M	12.3 M	8.06 M
Shares	366 K	366 K	126 K	109 K	69.6 K	58.2 K	55.8 K	46.3 K	37.3 K	31 K
Net Income	-16.3 M	-8.35 M	-4.92 M	-15.7 M	-21.1 M	-20.9 M	-22.6 M	-19.8 M	-10.1 M	-12.5 M
Revenue	13.5 K	15.4 K	260 K	260 K	16.2 K	10.4 K	18.8 K	110 K	408 K	391 K
EBITDA	-10.6 M	-8.49 M	-8.07 M	-13 M	-20.3 M	-18.8 M	-17.1 M	-12.3 M	-9.95 M	-12.8 M
Operating Expenses	10.7 M	-	-	-	-	-	-	12.6 M	-	13.4 M
General and Administrative Expenses	8.67 M	4.59 M	4.56 M	5.47 M	7.5 M	6.53 M	8.97 M	5.25 M	4.25 M	-